Pulse-Chase Labeling with 15N and AHA in an Alzheimer's Mouse Model
在阿尔茨海默病小鼠模型中使用 15N 和 AHA 进行脉冲追踪标记
基本信息
- 批准号:9107688
- 负责人:
- 金额:$ 9.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimalsBrainCellsChemistryDiseaseExtracellular MatrixFoodGoalsHealthLabelLengthLifeLongevityMaintenanceMeasurementMeasuresMethodsMitoticModelingMusNeuronsNuclear PorePhysiologic pulsePore ProteinsPrefrontal CortexProcessProtein FragmentProteinsProteolytic ProcessingProteomicsRadioisotopesRattusRecruitment ActivityResearchResearch ProposalsRoleSafetySystemTechniquesTimeTranslatingexpectationin vivomouse modelmulticatalytic endopeptidase complexprotein degradationprotein misfoldingresponse
项目摘要
DESCRIPTION (provided by applicant): The length of time a protein persists in a cell or the extracellular matrix can be an important determinant of the protein's role in disease. Over time proteins can be damaged or modified and then must be removed from the cell by proteolytic processes involving the proteasome or autophagic systems within the cell or by turnover of the whole cell. Accordingly, protein lifetimes and maintenance are particularly important in post-mitotic cells such as neurons. Traditionally, pulse-chase techniques using radioactive isotopes have been a method to measure the expression and turnover of proteins. We have developed an in vivo pulse-chase method using 15N labeled animals to measure the lifetimes of proteins and using these methods we observed surprisingly that inner core nuclear pore proteins are unexpectedly long- lived proteins. These studies used a linear rate decay analysis model in rats starting at 3 months and extending through 12 months. In this research proposal, we will label the Borchelt Alzheimer's disease mouse model with 15N and chase the labeled animal with 14N food. Measurement of the 14N to 15N ratios will determine the lifetime of APP, abeta1-42 and other proteins present in aggregates. Our expectation is that protein found in the aggregates will be long lived because the normal processes that remove misfolded proteins have failed. A second goal of this R03 proposal is to develop a method using L-azidohomoalanine (AHA) to measure the expression of newly translated proteins in mice. As proof of principle we have successfully pulse labeled a mouse with L-azidohomoalanine to determine safety and incorporation levels. In the proposed research we will pulse AHA in the mouse's food at set timepoints in a Borchelt Alzheimer's mouse model of Alzheimer's disease. We will enrich and measure proteins incorporating AHA in the prefrontal cortex and in insoluble brain aggregates. Only newly translated proteins should have incorporated AHA and will be enriched using "click" chemistry. We will identify new proteins being translated and recruited to the prefrontal cortex and to aggregates. Our hypothesis is that new proteins are being expressed and recruited to aggregates to help remove them.
描述(由申请人提供):蛋白质在细胞或细胞外基质中持续存在的时间长度可能是蛋白质在疾病中作用的重要决定因素。随着时间的推移,蛋白质可能被破坏或修饰,然后必须通过涉及细胞内蛋白酶体或自噬系统的蛋白质水解过程或整个细胞的周转从细胞中移除。因此,蛋白质的寿命和维持在有丝分裂后的细胞如神经元中尤为重要。传统上,使用放射性同位素的脉冲追踪技术一直是测量蛋白质表达和周转的一种方法。我们开发了一种体内脉冲追踪方法,使用15N标记的动物来测量蛋白质的寿命,并使用这些方法我们惊讶地观察到内核核孔蛋白是出乎意料的长寿蛋白质。这些研究采用线性速率衰减分析模型,从大鼠3个月开始,一直持续到12个月。在本研究计划中,我们将用15N标记Borchelt阿尔茨海默病小鼠模型,并用14N食物追赶标记的动物。测定14N和15N的比值将决定APP、β 1-42和其他蛋白在聚集体中的寿命。我们的期望是,在聚集体中发现的蛋白质将长期存在,因为去除错误折叠蛋白质的正常过程已经失败。R03提案的第二个目标是开发一种使用l -叠氮多同丙氨酸(AHA)来测量小鼠中新翻译蛋白表达的方法。作为原理证明,我们已经成功地用l -叠氮多同丙氨酸脉冲标记了一只老鼠,以确定安全性和掺入水平。在拟议的研究中,我们将在Borchelt阿尔茨海默氏病小鼠模型中,在设定的时间点对小鼠的食物进行AHA脉冲。我们将在前额皮质和不溶性脑聚集物中富集和测量含有AHA的蛋白质。只有新翻译的蛋白质应该包含AHA,并将通过“点击”化学富集。我们将发现新的蛋白质被翻译和招募到前额皮质和聚集体。我们的假设是,新的蛋白质正在被表达并聚集到聚集体中,以帮助清除它们。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John R Yates III其他文献
John R Yates III的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John R Yates III', 18)}}的其他基金
High Throughput Methods for Single Cell Proteomics
单细胞蛋白质组学的高通量方法
- 批准号:
10609071 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
Analysis of protein interactions in neurodegenerative disease
神经退行性疾病中蛋白质相互作用的分析
- 批准号:
10613978 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
High Throughput Methods for Single Cell Proteomics
单细胞蛋白质组学的高通量方法
- 批准号:
10433158 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry
用蛋白质组学和质谱法测量恶性肿瘤细胞中的异常蛋白质折叠
- 批准号:
9233438 - 财政年份:2017
- 资助金额:
$ 9.48万 - 项目类别:
Pulse-Chase Labeling with 15N and AHA in an Alzheimer's Mouse Model
在阿尔茨海默病小鼠模型中使用 15N 和 AHA 进行脉冲追踪标记
- 批准号:
8919211 - 财政年份:2014
- 资助金额:
$ 9.48万 - 项目类别:
Pulse-Chase Labeling with 15N and AHA in an Alzheimer's Mouse Model
在阿尔茨海默病小鼠模型中使用 15N 和 AHA 进行脉冲追踪标记
- 批准号:
8749039 - 财政年份:2014
- 资助金额:
$ 9.48万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 9.48万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 9.48万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 9.48万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 9.48万 - 项目类别: